Xbrane Biopharma AB(SE:XBRANE)
kr 11.70-0.35 (-2.90%)
SE:XBRANE
Xbrane Biopharma AB financials statements
kr 11.70
At close:-0.35 (-2.90%)
Want to see SE:XBRANE full AI Analyst Report?
Xbrane Biopharma AB (XBRANE) Income Statement
11 Followers
Xbrane Biopharma AB Income Statement
Last quarter (Q3 2026), Xbrane Biopharma AB's total revenue was kr54.77M, an increase of 441.31% from the same quarter last year. In Q3, Xbrane Biopharma AB's net income was kr-11.72M. See Xbrane Biopharma AB’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| kr 152.35M | kr 198.70M | kr 238.73M | kr 57.62M | kr 11.53M | |
| kr 74.94M | kr 180.47M | kr 35.39M | kr 41.04M | kr -684.00K | |
| kr 151.71M | kr 398.40M | kr 357.55M | kr 210.27M | kr 191.93M | |
| Depreciation and Amortization | kr 14.60M | kr 35.95M | kr 21.43M | kr 16.58M | kr 12.22M |
| kr -16.50M | kr -181.97M | kr -282.03M | kr -149.34M | kr -168.37M | |
| kr -72.14M | kr -217.92M | kr -310.43M | kr -166.22M | kr -180.40M | |
| kr 28.21M | kr -35.51M | kr -11.60M | kr -2.30M | kr -2.64M | |
| kr -43.93M | kr -253.43M | kr -322.03M | kr -168.51M | kr -183.23M | |
| kr 127.24M | kr -266.22M | kr -388.17M | kr -172.23M | kr -191.01M | |
| Per Share Metrics | |||||
| Basic EPS | kr 0.08 | kr -27.50 | kr -158.75 | kr -96.25 | kr -112.50 |
| Diluted EPS | kr 0.08 | kr -27.50 | kr -158.75 | kr -96.25 | kr -112.50 |
| Weighted Average Shares Outstanding | 1.52B | 9.84M | 2.03M | 1.80M | 1.66M |
| Weighted Average Shares Outstanding (Diluted) | 1.52B | 9.84M | 2.03M | 1.80M | 1.66M |
Currency in SEK
